Standard Biotools (LAB) Construction in Progress (2011 - 2026)
Standard Biotools' (LAB) quarterly Construction in Progress came in at $823000.0 in Q1 2026, down 88.23% year-on-year from $7.0 million in Q1 2025, and down 8.56% on a QoQ basis from $900000.0 in Q4 2025.
Standard Biotools (LAB) Construction in Progress (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has 16 years of Construction in Progress data on file, last reported at $823000.0 in Q1 2026.
- On a quarterly basis, Construction in Progress fell 88.23% year-over-year to $823000.0 in Q1 2026; TTM through Mar 2026 was $823000.0, a 88.23% decrease from a year earlier, with the FY2025 full-year figure at $900000.0, down 85.07% from the prior year.
- Construction in Progress for Q1 2026 stood at $823000.0, down from $900000.0 in the prior quarter.
- Over the last five years, Construction in Progress for LAB reached as high as $7.0 million in Q1 2025 and fell as low as $375000.0 in Q3 2025.
- Historically, Construction in Progress has averaged $2.8 million across 5 years, with a median of $2.1 million in 2022.
- Across the five-year window, Construction in Progress jumped 205.84% in 2024 and tumbled 93.97% in 2025, its largest moves.
- Year by year, Construction in Progress stood at $1.6 million in 2022, then soared by 44.79% to $2.3 million in 2023, then surged by 158.27% to $6.0 million in 2024, then tumbled by 85.07% to $900000.0 in 2025, then fell by 8.56% to $823000.0 in 2026.
- Per Business Quant data, the three most recent Construction in Progress figures were $823000.0 in Q1 2026, $900000.0 in Q4 2025, and $375000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.35 Bn | 180.06 Bn | 6.27 Bn | - |
| 2 | Stryker | 132.18 Bn | 129.31 Bn | 3.81 Bn | - |
| 3 | Medtronic | 111.47 Bn | 102.25 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.97 Bn | 67.51 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.83 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.00 Bn | 27.88 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.78 Bn | 26.49 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 28.00 Bn | 27.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.22 Bn | 2.01 Bn | - |
| 10 | Standard Biotools | 303.07 Mn | -152.11 Mn | 11.31 Mn | 823,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 823,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 473,000.00 |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 6.22 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 20.52 Mn |